|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mousavi SM, Gouya MM, Ramazani R, Davanlou
M, Hajsadeghi N and Seddighi Z: Cancer incidence and mortality in
Iran. Ann Oncol. 20:556–563. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Safaee A, Fatemi SR, Ashtari S, Vahedi M,
Moghimi-Dehkordi B and Zali MR: Four years incidence rate of
colorectal cancer in Iran: a survey of national cancer registry
data - implications for screening. Asian Pac J Cancer Prev.
13:2695–2698. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dolatkhah R, Somi MH, Kermani IA,
Ghojazadeh M, Jafarabadi MA, Farassati F and Dastgiri S: Increased
colorectal cancer incidence in Iran: A systematic review and
meta-analysis. BMC Public Health. 15:9972015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Worthley DL and Leggett BA: Colorectal
cancer: Molecular features and clinical opportunities. Clin Biochem
Rev. 31:31–38. 2010.PubMed/NCBI
|
|
7
|
Takayama T, Miyanishi K, Hayashi T, Sato Y
and Niitsu Y: Colorectal cancer: Genetics of development and
metastasis. J Gastroenterol. 41:185–192. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Issa JP: Colon cancer: It's CIN or CIMP.
Clin Cancer Res. 14:5939–5940. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Deaton AM and Bird A: CpG islands and the
regulation of transcription. Genes Dev. 25:1010–1022. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Illingworth RS, Gruenewald-Schneider U,
Webb S, Kerr AR, James KD, Turner DJ, Smith C, Harrison DJ, Andrews
R and Bird AP: Orphan CpG islands identify numerous conserved
promoters in the mammalian genome. PLoS Genet. 6:e10011342010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim MS, Lee J and Sidransky D: DNA
methylation markers in colorectal cancer. Cancer Metastasis Rev.
29:181–206. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kelly TK, De Carvalho DD and Jones PA:
Epigenetic modifications as therapeutic targets. Nat Biotechnol.
28:1069–1078. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Portela A and Esteller M: Epigenetic
modifications and human disease. Nat Biotechnol. 28:1057–1068.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fleischhacker M and Schmidt B: Circulating
nucleic acids (CNAs) and cancer-a survey. Biochim Biophys Acta.
1775:181–232. 2007.PubMed/NCBI
|
|
15
|
Iannolo G, Conticello C, Memeo L and De
Maria R: Apoptosis in normal and cancer stem cells. Crit Rev Oncol
Hematol. 66:42–51. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Oliver L and Vallette FM: The role of
caspases in cell death and differentiation. Drug Resist Updat.
8:163–170. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Qiao L and Wong BC: Targeting apoptosis as
an approach for gastrointestinal cancer therapy. Drug Resist Updat.
12:55–64. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ghobrial IM, Witzig TE and Adjei AA:
Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin.
55:178–194. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hector S and Prehn JH: Apoptosis signaling
proteins as prognostic biomarkers in colorectal cancer: A review.
Biochim Biophys Acta. 1795:117–129. 2009.PubMed/NCBI
|
|
20
|
Jones PA and Baylin SB: The fundamental
role of epigenetic events in cancer. Nat Rev Genet. 3:415–428.
2002.PubMed/NCBI
|
|
21
|
Manoochehri M, Karbasi A, Bandehpour M and
Kazemi B: Down-regulation of BAX gene during carcinogenesis and
acquisition of resistance to 5-FU in colorectal cancer. Pathol
Oncol Res. 20:301–307. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rupnarain C, Dlamini Z, Naicker S and
Bhoola K: Colon cancer: genomics and apoptotic events. Biol Chem.
385:449–464. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li LC and Dahiya R: MethPrimer: Designing
primers for methylation PCRs. Bioinformatics. 18:1427–1431. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Elmore S: Apoptosis: A review of
programmed cell death. Toxicol Pathol:. 35:495–516. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Aaltonen LA and Hamilton SR: World Health
Organization classification of tumours: Pathology and genetics of
tumours of the digestive system. IARC Press. Lyon: 2000.
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Petak I, Danam RP, Tillman DM, Vernes R,
Howell SR, Berczi L, Kopper L, Brent TP and Houghton JA:
Hypermethylation of the gene promoter and enhancer region can
regulate Fas expression and sensitivity in colon carcinoma. Cell
Death Differ. 10:211–217. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Coppedè F: Epigenetic biomarkers of
colorectal cancer: Focus on DNA methylation. Cancer Lett.
342:238–247. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Choong MK and Tsafnat G: Genetic and
epigenetic biomarkers of colorectal cancer. Clin Gastroenterol
Hepatol. 10:9–15. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Binefa G, Rodríguez-Moranta F, Teule A and
Medina-Hayas M: Colorectal cancer: From prevention to personalized
medicine. World J Gastroenterol. 20:6786–6808. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shivapurkar N and Gazdar AF: DNA
methylation based biomarkers in non-invasive cancer screening. Curr
Mol Med. 10:123–132. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lao VV and Grady WM: Epigenetics and
colorectal cancer. Nat Rev Gastroenterol Hepatol. 8:686–700. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Singh R, Pradhan V, Patwardhan M and Ghosh
K: APO-1/Fas gene: Structural and functional characteristics in
systemic lupus erythematosus and other autoimmune diseases. Indian
J Hum Genet. 15:98–102. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Butler LM, Dobrovic A, Bianco T and Cowled
PA: Promoter region methylation does not account for the frequent
loss of expression of the Fas gene in colorectal carcinoma. Br J
Cancer. 82:131–135. 2000.PubMed/NCBI
|
